Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Kevin Lillehei

Concepts (614)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
48
2023
1170
3.220
Why?
Pituitary Neoplasms
27
2024
183
2.770
Why?
Adenoma
21
2020
212
2.340
Why?
Meningioma
12
2022
81
2.070
Why?
Pituitary Gland
11
2020
148
1.790
Why?
Glioblastoma
18
2023
326
1.680
Why?
Central Nervous System Cysts
3
2020
13
1.680
Why?
Neoplasm Recurrence, Local
19
2022
959
1.490
Why?
Meningeal Neoplasms
6
2022
93
1.370
Why?
Neurosurgical Procedures
10
2021
173
1.310
Why?
Peripheral Nervous System Neoplasms
6
2009
19
1.140
Why?
Central Nervous System Neoplasms
7
2017
149
0.980
Why?
Glioma
15
2020
354
0.970
Why?
Radiotherapy, Intensity-Modulated
5
2016
129
0.890
Why?
Sphenoid Bone
2
2016
15
0.890
Why?
Gliosarcoma
5
2006
8
0.880
Why?
Cysts
3
2020
108
0.790
Why?
Carmustine
3
2017
50
0.750
Why?
Pituitary ACTH Hypersecretion
2
2018
10
0.730
Why?
Cancer Vaccines
5
2018
164
0.720
Why?
Neoplasms, Radiation-Induced
4
2008
71
0.720
Why?
Hypopituitarism
1
2020
15
0.680
Why?
Rhabdoid Tumor
3
2010
98
0.660
Why?
Antibiotics, Antineoplastic
2
2019
123
0.630
Why?
Radiotherapy, Adjuvant
2
2016
210
0.620
Why?
Polyesters
2
2017
72
0.590
Why?
Immunotherapy
4
2006
592
0.590
Why?
Decanoic Acids
1
2017
8
0.580
Why?
Bleomycin
1
2019
244
0.580
Why?
Magnetic Resonance Imaging
29
2022
3390
0.580
Why?
Adult
71
2024
35471
0.550
Why?
Middle Aged
72
2024
31075
0.540
Why?
Orbital Diseases
1
2016
28
0.530
Why?
Aged
53
2024
22030
0.500
Why?
Male
85
2024
63498
0.460
Why?
Humans
124
2024
129219
0.450
Why?
Female
82
2024
68607
0.430
Why?
Brachial Plexus
3
2007
28
0.410
Why?
Antineoplastic Agents
5
2017
2058
0.410
Why?
Biomarkers, Tumor
8
2017
1181
0.400
Why?
Retrospective Studies
27
2024
14488
0.400
Why?
Dacarbazine
7
2015
94
0.390
Why?
Chemoradiotherapy
4
2015
210
0.380
Why?
Skull Neoplasms
4
2012
23
0.380
Why?
Immunotherapy, Adoptive
5
1997
295
0.370
Why?
Cisplatin
3
1998
298
0.370
Why?
Craniopharyngioma
3
2020
82
0.360
Why?
Extracellular Vesicles
2
2024
130
0.360
Why?
Cautery
1
2010
4
0.350
Why?
Antineoplastic Agents, Alkylating
5
2013
69
0.340
Why?
Epithelioid Cells
1
2010
8
0.340
Why?
Sella Turcica
5
2018
16
0.340
Why?
Monosomy
1
2010
11
0.340
Why?
ACTH-Secreting Pituitary Adenoma
2
2024
11
0.340
Why?
Chromosomes, Human, Pair 22
1
2010
41
0.340
Why?
Astrocytoma
5
2014
122
0.330
Why?
Neurosurgery
2
2021
37
0.330
Why?
Combined Modality Therapy
11
2016
1202
0.330
Why?
Fibromatosis, Aggressive
2
2007
17
0.330
Why?
Hemangioma
1
2009
44
0.320
Why?
Chromosomal Proteins, Non-Histone
1
2010
116
0.320
Why?
Cadherins
2
2024
188
0.310
Why?
In Situ Hybridization, Fluorescence
6
2010
315
0.310
Why?
Membrane Proteins
2
2017
1115
0.300
Why?
Sarcoma, Ewing
1
2009
89
0.290
Why?
Spinal Nerve Roots
2
2006
25
0.290
Why?
DNA Mutational Analysis
3
2014
387
0.280
Why?
Fibromatosis, Abdominal
1
2007
3
0.280
Why?
Tumor Cells, Cultured
8
2017
939
0.280
Why?
Young Adult
15
2024
12403
0.270
Why?
Immunohistochemistry
13
2011
1696
0.270
Why?
Gene Expression Regulation, Neoplastic
9
2024
1354
0.270
Why?
Prolactinoma
3
2019
12
0.270
Why?
Brachial Plexus Neuropathies
1
2006
11
0.260
Why?
Diagnosis, Differential
8
2010
1424
0.260
Why?
Transforming Growth Factor beta2
1
2006
35
0.260
Why?
Oligonucleotides, Antisense
1
2006
113
0.250
Why?
Growth Hormone-Secreting Pituitary Adenoma
2
2017
11
0.250
Why?
Gonadotrophs
5
2015
21
0.250
Why?
Proto-Oncogene Proteins c-kit
1
2006
68
0.250
Why?
Ethanol
1
2010
587
0.250
Why?
Neoplasms
5
2013
2467
0.240
Why?
Rats, Inbred F344
7
2006
257
0.240
Why?
Oligonucleotide Array Sequence Analysis
7
2015
768
0.230
Why?
Interleukin-2
6
1997
436
0.230
Why?
Treatment Outcome
12
2020
10189
0.230
Why?
Chordoma
1
2024
16
0.230
Why?
Postoperative Complications
8
2018
2476
0.230
Why?
Adolescent
20
2020
20378
0.230
Why?
Hemangioblastoma
1
2004
3
0.220
Why?
DNA-Binding Proteins
2
2010
1443
0.220
Why?
Neoplasms, Second Primary
4
2012
106
0.220
Why?
Adrenocorticotropic Hormone
1
2004
133
0.220
Why?
Osteoblasts
1
2024
124
0.220
Why?
Cell Movement
2
2024
941
0.220
Why?
Neurologic Examination
3
2019
114
0.210
Why?
Transcription Factors
2
2010
1649
0.210
Why?
Cauda Equina
2
2004
6
0.210
Why?
Inappropriate ADH Syndrome
2
2018
8
0.210
Why?
Neuroendocrine Tumors
1
2024
99
0.210
Why?
Postoperative Period
3
2020
327
0.210
Why?
Drug Implants
3
2017
83
0.210
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2015
1565
0.200
Why?
Epithelial-Mesenchymal Transition
1
2024
202
0.200
Why?
Motor Cortex
1
2003
58
0.200
Why?
Tumor Suppressor Protein p53
4
2012
511
0.200
Why?
T-Lymphocytes, Cytotoxic
3
2000
169
0.200
Why?
Pituitary Diseases
3
2017
21
0.190
Why?
Fistula
1
2022
35
0.190
Why?
Prognosis
10
2021
3791
0.190
Why?
Pancreatic Neoplasms
1
2009
879
0.190
Why?
Frontal Bone
2
2015
12
0.190
Why?
Pineal Gland
1
2021
17
0.190
Why?
Pinealoma
1
2021
11
0.190
Why?
Aspergillus
2
2013
15
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2014
212
0.190
Why?
Neoplasms, Multiple Primary
2
2016
54
0.180
Why?
Follow-Up Studies
8
2017
4886
0.180
Why?
Intracranial Hypotension
1
2022
40
0.180
Why?
Prospective Studies
11
2023
7103
0.180
Why?
Ki-67 Antigen
4
2011
109
0.180
Why?
Neuropathology
1
2020
4
0.180
Why?
Telepathology
1
2020
4
0.180
Why?
Tumor Microenvironment
1
2024
634
0.170
Why?
Radiosurgery
3
2010
319
0.170
Why?
Paraneoplastic Endocrine Syndromes
1
2000
1
0.170
Why?
Esthesioneuroblastoma, Olfactory
1
2000
1
0.170
Why?
Reactive Oxygen Species
2
2000
595
0.170
Why?
Salivary Glands
1
2020
29
0.170
Why?
Survival Analysis
7
2018
1271
0.170
Why?
Stereotaxic Techniques
1
2020
38
0.170
Why?
Fluorescein
1
2020
25
0.170
Why?
Transcriptome
3
2024
885
0.170
Why?
Nose Neoplasms
1
2000
16
0.170
Why?
Tomography, X-Ray Computed
12
2022
2525
0.170
Why?
Paranasal Sinus Neoplasms
1
2000
23
0.170
Why?
Lung Neoplasms
3
2013
2339
0.160
Why?
Genes, Tumor Suppressor
2
2017
86
0.160
Why?
Aged, 80 and over
12
2020
7061
0.160
Why?
Neoplasm Grading
2
2017
285
0.160
Why?
Sphenoid Sinusitis
1
2018
4
0.160
Why?
Dendritic Cells
2
2023
477
0.160
Why?
Hemangioma, Cavernous
1
1998
13
0.160
Why?
Polyethylenes
1
2018
14
0.150
Why?
Stroke
2
2021
1064
0.150
Why?
Chemotherapy, Adjuvant
5
2015
381
0.150
Why?
Oligodendroglioma
2
2014
15
0.150
Why?
Endocrine Glands
1
1998
15
0.150
Why?
International Educational Exchange
1
2018
12
0.150
Why?
ErbB Receptors
4
2006
606
0.150
Why?
Antioxidants
2
2000
557
0.150
Why?
Survival Rate
6
2015
1874
0.150
Why?
Time Factors
10
2011
6549
0.150
Why?
Sphenoid Sinus
1
2018
8
0.150
Why?
Hyponatremia
1
2018
40
0.150
Why?
Adenocarcinoma
2
2004
895
0.150
Why?
Remission Induction
1
2018
269
0.140
Why?
Cerebrovascular Disorders
1
1998
90
0.140
Why?
Mutation
3
2014
3715
0.140
Why?
Contraceptives, Oral, Hormonal
1
2017
31
0.140
Why?
Quinazolines
2
2010
244
0.140
Why?
Prostheses and Implants
1
2018
132
0.140
Why?
Gene Expression Profiling
5
2024
1705
0.140
Why?
Rats
8
2006
5462
0.140
Why?
Thalamic Diseases
1
2017
3
0.140
Why?
Reoperation
5
2020
543
0.140
Why?
Xanthomatosis
1
2017
11
0.140
Why?
Desmosomes
1
2017
21
0.140
Why?
Third Ventricle
1
2017
17
0.140
Why?
Students, Medical
1
2021
315
0.140
Why?
Exophthalmos
1
2016
17
0.130
Why?
Brain Injuries
1
2021
467
0.130
Why?
Cell Proliferation
5
2015
2388
0.130
Why?
Cytokines
2
2021
2011
0.130
Why?
Carcinoma, Non-Small-Cell Lung
1
2004
1049
0.130
Why?
Progesterone
1
2017
243
0.130
Why?
Receptors, Somatostatin
1
2015
24
0.120
Why?
Neurothekeoma
1
1995
4
0.120
Why?
Tibial Nerve
1
1995
9
0.120
Why?
Occipital Lobe
2
2006
24
0.120
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2015
73
0.120
Why?
Glycoproteins
3
2012
338
0.120
Why?
Genes, p53
2
2011
70
0.120
Why?
Proteome
2
2024
443
0.120
Why?
Accidents, Aviation
1
1994
4
0.120
Why?
Molecular Chaperones
2
2013
182
0.120
Why?
Antigens, Neoplasm
2
2013
309
0.120
Why?
Orbit
1
2015
57
0.120
Why?
Karyotyping
3
2008
107
0.120
Why?
Biocompatible Materials
1
2018
395
0.120
Why?
Olfactory Pathways
1
2015
60
0.120
Why?
Cranial Irradiation
1
1995
68
0.120
Why?
Neoplasm Invasiveness
6
2014
481
0.120
Why?
Acromegaly
1
2014
12
0.120
Why?
Spinal Cord Neoplasms
1
2014
40
0.110
Why?
Intervertebral Disc Displacement
2
1998
39
0.110
Why?
Ganglioglioma
1
2014
31
0.110
Why?
Human Growth Hormone
1
2014
45
0.110
Why?
Orbital Neoplasms
1
2014
20
0.110
Why?
Seizures
1
2017
402
0.110
Why?
Pituitary Gland, Posterior
1
2013
2
0.110
Why?
Ganglioneuroma
1
2013
2
0.110
Why?
Cerebral Hemorrhage
2
1985
107
0.110
Why?
Child
9
2022
20853
0.110
Why?
Immune Tolerance
2
2008
354
0.110
Why?
Sarcoma, Alveolar Soft Part
1
1993
7
0.110
Why?
Aspergillosis
1
2013
20
0.110
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2013
19
0.110
Why?
Telomerase
3
2003
233
0.100
Why?
Joint Dislocations
1
1993
50
0.100
Why?
Cell Division
5
2012
796
0.100
Why?
Dog Diseases
1
2013
52
0.100
Why?
Spinal Injuries
1
1993
52
0.100
Why?
Patient Readmission
1
2018
664
0.100
Why?
Neoplasm Transplantation
3
2000
257
0.100
Why?
Immunoglobulin Heavy Chains
2
2009
80
0.100
Why?
Polymerase Chain Reaction
4
2012
1036
0.100
Why?
Muscles
1
1993
322
0.100
Why?
Soft Tissue Neoplasms
1
1993
112
0.100
Why?
Craniotomy
3
2015
68
0.100
Why?
Curriculum
1
2018
918
0.100
Why?
Isocitrate Dehydrogenase
1
2012
52
0.100
Why?
Drug Resistance, Multiple
2
2001
24
0.090
Why?
Spine
1
1993
158
0.090
Why?
Skull
2
2007
129
0.090
Why?
Research Design
1
2017
1038
0.090
Why?
Cell Line, Tumor
4
2024
3211
0.090
Why?
Antigens, Differentiation
1
2011
81
0.090
Why?
Mitotic Index
2
2011
26
0.090
Why?
Fibrous Dysplasia, Polyostotic
1
2010
7
0.090
Why?
Hyperthermia, Induced
2
2002
109
0.090
Why?
Severity of Illness Index
1
2019
2736
0.090
Why?
Adenoma, Oxyphilic
1
2010
6
0.090
Why?
Tumor Burden
4
2012
285
0.080
Why?
Claudins
1
2010
25
0.080
Why?
SMARCB1 Protein
1
2010
29
0.080
Why?
Registries
1
2017
1886
0.080
Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2009
13
0.080
Why?
Animals
14
2013
35219
0.080
Why?
Lymphoma
2
2008
195
0.080
Why?
Tanzania
2
2020
44
0.080
Why?
Immunity, Cellular
2
2003
264
0.080
Why?
Neuroaspergillosis
1
2008
2
0.080
Why?
Tumor Suppressor Proteins
1
2011
317
0.080
Why?
Piperidines
1
2010
196
0.080
Why?
Brain Abscess
1
2008
10
0.080
Why?
Killer Cells, Lymphokine-Activated
4
1993
12
0.080
Why?
Internship and Residency
1
2018
1049
0.080
Why?
Cell Survival
5
2015
1085
0.080
Why?
Cytogenetics
1
2008
12
0.080
Why?
Genetic Vectors
2
2008
312
0.080
Why?
Dogs
2
2013
378
0.070
Why?
Arm Injuries
1
1988
27
0.070
Why?
Cell Cycle Proteins
1
2012
586
0.070
Why?
Prolactin
3
2019
98
0.070
Why?
Cytotoxicity, Immunologic
3
2006
220
0.070
Why?
Wounds and Injuries
1
1994
708
0.070
Why?
Radiotherapy Dosage
3
2010
251
0.070
Why?
Wounds, Penetrating
1
1988
63
0.070
Why?
Drug Administration Schedule
3
2010
767
0.070
Why?
Interferon-beta
1
2008
89
0.070
Why?
Epstein-Barr Virus Infections
1
2008
93
0.070
Why?
Mesenchymoma
1
2007
7
0.070
Why?
Nerve Sheath Neoplasms
1
2007
10
0.070
Why?
Carcinoma, Adenoid Cystic
1
2007
18
0.070
Why?
Hematoma
2
1985
54
0.070
Why?
Superoxide Dismutase
2
2000
342
0.070
Why?
Scalp
1
2007
34
0.070
Why?
Adenoviridae
1
2008
192
0.070
Why?
Neoplasm Staging
4
2015
1292
0.070
Why?
Neoplastic Syndromes, Hereditary
1
2007
38
0.070
Why?
Radiography
3
2013
798
0.070
Why?
Blood Vessels
1
1988
187
0.070
Why?
Child, Preschool
5
2017
10507
0.070
Why?
Multiple Sclerosis
1
2012
436
0.070
Why?
Enophthalmos
1
2006
2
0.070
Why?
Base Pair Mismatch
1
2006
11
0.070
Why?
Dexamethasone
4
2012
346
0.070
Why?
Hemangioma, Capillary
1
2006
13
0.070
Why?
Blepharoptosis
1
2006
8
0.060
Why?
Injections, Subcutaneous
1
2006
147
0.060
Why?
Epidermal Cyst
1
2006
12
0.060
Why?
Immunoprecipitation
1
2006
157
0.060
Why?
Imatinib Mesylate
1
2006
76
0.060
Why?
Vaccination
2
2023
1348
0.060
Why?
Parietal Lobe
1
2006
49
0.060
Why?
Lymphoma, Follicular
1
2006
38
0.060
Why?
Teratoma
1
2007
105
0.060
Why?
Brain Edema
2
2004
60
0.060
Why?
Genetic Therapy
1
2008
292
0.060
Why?
Chest Pain
1
2006
89
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2008
442
0.060
Why?
Karnofsky Performance Status
3
2013
38
0.060
Why?
Bone Diseases
1
2006
57
0.060
Why?
Neoplasm, Residual
2
2020
119
0.060
Why?
Ultrasonics
2
2002
49
0.060
Why?
Benzamides
1
2006
207
0.060
Why?
Maximum Tolerated Dose
3
2010
193
0.060
Why?
Wounds, Nonpenetrating
1
1988
272
0.060
Why?
Lymphoma, B-Cell
1
2006
105
0.060
Why?
Databases, Factual
1
2010
1269
0.060
Why?
Disease Models, Animal
2
2006
4049
0.060
Why?
Exons
1
2006
342
0.060
Why?
Cushing Syndrome
1
2004
10
0.060
Why?
Medulloblastoma
1
2007
198
0.060
Why?
Myelography
2
2022
29
0.060
Why?
Predictive Value of Tests
1
2010
1944
0.060
Why?
Calcitonin
1
2004
27
0.060
Why?
United States
3
2017
13873
0.060
Why?
Bevacizumab
2
2015
129
0.060
Why?
Subarachnoid Space
1
2004
8
0.060
Why?
S100 Proteins
2
1995
36
0.060
Why?
von Hippel-Lindau Disease
1
2004
12
0.060
Why?
Brain
6
2017
2664
0.050
Why?
Radiotherapy
1
2004
187
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2011
958
0.050
Why?
Cranial Fossa, Posterior
2
2012
17
0.050
Why?
Neoplasms, Neuroepithelial
1
2003
17
0.050
Why?
Piperazines
1
2006
342
0.050
Why?
Craniocerebral Trauma
1
1985
151
0.050
Why?
Proteomics
2
2024
1061
0.050
Why?
Lymphocyte Activation
3
1993
1106
0.050
Why?
Quality of Life
2
2013
2693
0.050
Why?
Image Enhancement
1
2004
163
0.050
Why?
Age Factors
4
2014
3137
0.050
Why?
Dura Mater
2
2000
30
0.050
Why?
Polymers
2
1997
479
0.050
Why?
Nerve Tissue Proteins
1
2006
569
0.050
Why?
Incidence
3
2003
2638
0.050
Why?
Disease Progression
2
2021
2622
0.050
Why?
Pyrimidines
1
2006
459
0.050
Why?
Neoplasm Proteins
2
2003
424
0.050
Why?
Hydrocortisone
1
2004
305
0.050
Why?
Transferases
1
2022
33
0.050
Why?
Transforming Growth Factor beta
1
2024
457
0.050
Why?
Microtubule-Associated Proteins
1
2003
191
0.050
Why?
Case-Control Studies
2
2021
3372
0.050
Why?
DNA, Neoplasm
3
2005
159
0.050
Why?
Cerebrospinal Fluid Leak
1
2022
47
0.050
Why?
Spinal Cord
1
2004
356
0.050
Why?
Thyrotropin
5
1999
109
0.050
Why?
Public Opinion
1
2021
63
0.050
Why?
Drug Resistance, Neoplasm
2
2003
755
0.040
Why?
Neuroimmunomodulation
1
2000
69
0.040
Why?
Gene Amplification
2
2015
105
0.040
Why?
Ethmoid Sinus
1
2000
7
0.040
Why?
Vulnerable Populations
1
2021
157
0.040
Why?
Frontal Sinus
1
2000
5
0.040
Why?
Arginine Vasopressin
1
2000
42
0.040
Why?
Visual Fields
1
2020
87
0.040
Why?
Surgical Wound Infection
1
2003
282
0.040
Why?
Free Radicals
1
2000
106
0.040
Why?
Immunosuppressive Agents
2
2008
840
0.040
Why?
Pituitary Hormones
1
1999
16
0.040
Why?
Dopamine Agonists
1
2019
39
0.040
Why?
Gonadotropins, Pituitary
2
2008
22
0.040
Why?
Recurrence
1
2023
1005
0.040
Why?
Chromosomes, Human, Pair 7
2
2005
15
0.040
Why?
Skin Neoplasms
1
2007
823
0.040
Why?
Cerebral Cortex
2
1998
432
0.040
Why?
Depressive Disorder, Major
1
2003
345
0.040
Why?
Drug Delivery Systems
1
2002
335
0.040
Why?
Infant
2
2008
9016
0.040
Why?
Hot Temperature
1
2001
366
0.040
Why?
Up-Regulation
2
2015
837
0.040
Why?
Injections, Intralesional
1
1998
34
0.040
Why?
Apoptosis
2
2015
2501
0.040
Why?
Cerebral Veins
1
1998
15
0.040
Why?
Biopsy
2
2017
1087
0.040
Why?
Smooth Muscle Tumor
1
1998
6
0.040
Why?
Catheters, Indwelling
1
1998
79
0.040
Why?
Sarcoma, Synovial
1
1998
17
0.040
Why?
Visual Acuity
1
2020
322
0.040
Why?
Leiomyosarcoma
1
1998
27
0.040
Why?
Capacity Building
1
2018
59
0.040
Why?
Preoperative Care
2
2003
336
0.040
Why?
Tertiary Care Centers
1
2018
151
0.040
Why?
Endpoint Determination
1
2018
76
0.040
Why?
Meningomyelocele
1
1998
59
0.040
Why?
Drug Synergism
1
1998
369
0.040
Why?
Cell Transformation, Neoplastic
1
2000
328
0.040
Why?
Cell Line
3
2012
2777
0.040
Why?
Brain Diseases
2
1998
137
0.040
Why?
Hypophysitis
1
2017
3
0.040
Why?
Neuroectodermal Tumors, Primitive
1
1997
11
0.030
Why?
Interferon-gamma
1
2000
769
0.030
Why?
Leiomyoma
1
1998
74
0.030
Why?
Ventriculostomy
1
2017
22
0.030
Why?
Premenopause
1
2017
121
0.030
Why?
Neuroendoscopy
1
2017
19
0.030
Why?
Hydrocephalus
2
2017
107
0.030
Why?
Gonadotropins
2
1999
38
0.030
Why?
Microarray Analysis
1
2017
122
0.030
Why?
RNA, Messenger
5
2011
2702
0.030
Why?
DNA Methylation
1
2022
607
0.030
Why?
Postoperative Care
1
1998
238
0.030
Why?
Injections, Intraperitoneal
1
1996
110
0.030
Why?
Immunoenzyme Techniques
2
2012
213
0.030
Why?
Granuloma
1
2017
89
0.030
Why?
Cerebrospinal Fluid
1
2017
90
0.030
Why?
Biodegradation, Environmental
1
1996
82
0.030
Why?
Developing Countries
1
2018
286
0.030
Why?
Endoscopy
1
2018
270
0.030
Why?
Intraoperative Complications
1
2017
130
0.030
Why?
Immunophenotyping
1
1997
311
0.030
Why?
Cognition Disorders
2
2015
503
0.030
Why?
Delayed-Action Preparations
1
1997
173
0.030
Why?
Drainage
1
2017
165
0.030
Why?
Practice Patterns, Physicians'
1
2005
1264
0.030
Why?
Hyperostosis
1
1995
5
0.030
Why?
Endothelium, Vascular
1
2002
898
0.030
Why?
Signal Transduction
3
2015
4913
0.030
Why?
Computational Biology
1
2020
597
0.030
Why?
Diagnostic Imaging
1
1998
334
0.030
Why?
Olfactory Nerve
1
2015
9
0.030
Why?
Faculty, Medical
1
2018
263
0.030
Why?
Lactic Acid
1
1997
302
0.030
Why?
Anticonvulsants
1
2017
209
0.030
Why?
Cysticercosis
1
1995
3
0.030
Why?
Tumor Stem Cell Assay
1
2015
32
0.030
Why?
Cells, Cultured
3
2006
4072
0.030
Why?
DNA
1
2022
1399
0.030
Why?
Cytoprotection
1
2015
56
0.030
Why?
Neural Cell Adhesion Molecules
1
1995
29
0.030
Why?
Audiometry
1
1995
27
0.030
Why?
Colorado
2
2018
4412
0.030
Why?
Nasal Cavity
1
2015
50
0.030
Why?
Cerebral Infarction
1
1995
42
0.030
Why?
Seat Belts
1
1994
20
0.030
Why?
Aircraft
1
1994
22
0.030
Why?
Cerebral Arteries
1
2015
60
0.030
Why?
Mutant Proteins
1
2015
99
0.030
Why?
Gait Disorders, Neurologic
1
2015
44
0.030
Why?
Cerebral Angiography
1
1995
108
0.030
Why?
Marital Status
1
2014
44
0.030
Why?
Recombinant Proteins
3
1993
1303
0.030
Why?
Neuropsychological Tests
2
2013
1006
0.030
Why?
Personality Disorders
1
2015
73
0.030
Why?
Neuroimaging
1
2016
279
0.030
Why?
Computer Simulation
1
1998
941
0.030
Why?
Image Processing, Computer-Assisted
1
1998
742
0.030
Why?
DNA Copy Number Variations
1
2015
170
0.030
Why?
Cohort Studies
2
2017
5408
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2015
274
0.030
Why?
Cell Hypoxia
1
2015
234
0.030
Why?
Minimally Invasive Surgical Procedures
1
2015
170
0.030
Why?
SEER Program
1
2014
206
0.030
Why?
Paresis
2
2007
30
0.030
Why?
Nervous System
1
1993
67
0.030
Why?
Hypothyroidism
2
1992
70
0.030
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
270
0.030
Why?
Models, Biological
1
2000
1718
0.030
Why?
Mice
4
2012
16861
0.030
Why?
Phosphopyruvate Hydratase
1
1992
26
0.030
Why?
Antibodies, Monoclonal
4
2008
1364
0.030
Why?
Chronic Disease
1
2018
1713
0.030
Why?
Neuroblastoma
1
1993
154
0.020
Why?
Safety
1
1994
330
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2015
431
0.020
Why?
Cyclophosphamide
1
1993
229
0.020
Why?
Protein Structure, Tertiary
1
2015
837
0.020
Why?
Fatal Outcome
2
2007
300
0.020
Why?
G2 Phase
1
2012
36
0.020
Why?
Drug Screening Assays, Antitumor
1
1993
195
0.020
Why?
Reproducibility of Results
1
2020
3067
0.020
Why?
Vimentin
1
1992
51
0.020
Why?
Dose-Response Relationship, Drug
1
1996
2003
0.020
Why?
Lymphocytosis
1
1992
10
0.020
Why?
Rhodamine 123
2
2001
6
0.020
Why?
Active Transport, Cell Nucleus
1
2012
113
0.020
Why?
Lymphocytes
1
1993
373
0.020
Why?
CpG Islands
1
2012
152
0.020
Why?
Stress, Physiological
1
2015
413
0.020
Why?
Cavernous Sinus
1
2011
17
0.020
Why?
Analysis of Variance
1
2014
1285
0.020
Why?
Cytoplasm
1
2012
263
0.020
Why?
Skull Base
1
2011
43
0.020
Why?
Recovery of Function
1
2015
640
0.020
Why?
Cytotoxicity Tests, Immunologic
1
1991
41
0.020
Why?
Green Fluorescent Proteins
1
2012
385
0.020
Why?
Intraoperative Care
2
2003
45
0.020
Why?
PTEN Phosphohydrolase
1
2012
161
0.020
Why?
Algorithms
1
1998
1618
0.020
Why?
Spleen
1
1993
506
0.020
Why?
Carcinoma
1
2012
216
0.020
Why?
Retreatment
1
2010
69
0.020
Why?
Carboplatin
1
2010
140
0.020
Why?
Vincristine
1
2010
109
0.020
Why?
Vision Disorders
2
2007
135
0.020
Why?
Camptothecin
1
2010
109
0.020
Why?
Microscopy, Electron, Transmission
1
2010
146
0.020
Why?
T-Lymphocytes, Regulatory
1
1993
375
0.020
Why?
Doxorubicin
2
2001
325
0.020
Why?
Necrosis
1
2010
232
0.020
Why?
Salvage Therapy
1
2010
134
0.020
Why?
Hypogonadism
1
1990
84
0.020
Why?
Ultrasonography
2
1984
713
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2008
19
0.020
Why?
Follicle Stimulating Hormone
3
1999
236
0.020
Why?
Antigens, CD20
1
2008
27
0.020
Why?
DNA Damage
1
2011
384
0.020
Why?
Kinetics
1
1992
1641
0.020
Why?
Axillary Artery
1
1988
12
0.020
Why?
Sex Factors
1
2014
1961
0.020
Why?
Subclavian Artery
1
1988
27
0.020
Why?
CD3 Complex
1
2008
103
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2008
87
0.020
Why?
Anti-Inflammatory Agents
1
2012
478
0.020
Why?
Infant, Newborn
3
1997
5753
0.020
Why?
Administration, Oral
1
2010
783
0.020
Why?
Autoimmune Diseases
1
1992
426
0.020
Why?
Risk Assessment
1
2017
3234
0.020
Why?
Linear Models
1
2010
818
0.020
Why?
Mental Status Schedule
1
2007
34
0.020
Why?
Rituximab
1
2008
162
0.020
Why?
Promoter Regions, Genetic
1
2012
1206
0.020
Why?
DNA Primers
2
1999
510
0.020
Why?
Methotrexate
1
2008
249
0.020
Why?
Proportional Hazards Models
1
2010
1201
0.020
Why?
Intercellular Signaling Peptides and Proteins
1
2008
375
0.020
Why?
Pregnancy Complications
1
1992
492
0.020
Why?
Microscopy, Electron
1
2007
425
0.020
Why?
In Vitro Techniques
2
1989
1083
0.020
Why?
Multigene Family
1
2007
199
0.020
Why?
Glucocorticoids
1
2010
574
0.020
Why?
Bone Morphogenetic Proteins
1
2006
131
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2008
398
0.020
Why?
Tretinoin
1
2006
128
0.020
Why?
Interleukin-10
1
2008
303
0.020
Why?
Coma
1
1985
32
0.020
Why?
Cognition
1
2013
1114
0.020
Why?
Data Interpretation, Statistical
1
2007
335
0.020
Why?
Intracranial Pressure
1
1985
45
0.010
Why?
Athletic Injuries
1
1991
510
0.010
Why?
Action Potentials
1
1988
485
0.010
Why?
Blood-Brain Barrier
1
1985
128
0.010
Why?
Prostatic Neoplasms
1
2012
1016
0.010
Why?
Brain Concussion
1
1991
548
0.010
Why?
Citrates
1
1984
42
0.010
Why?
Interleukin-6
1
2008
720
0.010
Why?
Antigens, CD
1
2006
488
0.010
Why?
Genetic Predisposition to Disease
1
2012
2281
0.010
Why?
Blood
1
1984
103
0.010
Why?
Sound
1
1984
67
0.010
Why?
Inhibitor of Apoptosis Proteins
1
2003
45
0.010
Why?
Injections
1
1984
172
0.010
Why?
Trauma Centers
1
1985
401
0.010
Why?
Heparin
1
1984
253
0.010
Why?
Microcirculation
1
2002
145
0.010
Why?
Biological Transport, Active
1
2001
78
0.010
Why?
Cyclosporins
1
2001
77
0.010
Why?
Pulsatile Flow
2
1991
59
0.010
Why?
Ultrasonic Therapy
1
2001
11
0.010
Why?
Verapamil
1
2001
41
0.010
Why?
Gene Expression
1
2006
1469
0.010
Why?
Respiration, Artificial
1
1985
609
0.010
Why?
Calcium Channel Blockers
1
2001
159
0.010
Why?
Lung
1
2013
3916
0.010
Why?
Luteinizing Hormone
2
1991
179
0.010
Why?
Fushi Tarazu Transcription Factors
1
1999
5
0.010
Why?
Steroidogenic Factor 1
1
1999
6
0.010
Why?
Transcription Factor Pit-1
1
1999
24
0.010
Why?
Cattle
1
2002
977
0.010
Why?
Amino Acid Sequence
1
2003
2056
0.010
Why?
Brown-Sequard Syndrome
1
1998
5
0.010
Why?
Syringomyelia
1
1998
12
0.010
Why?
Molecular Sequence Data
1
2003
2830
0.010
Why?
Pyramidal Tracts
1
1998
26
0.010
Why?
Sensation Disorders
1
1998
32
0.010
Why?
Iatrogenic Disease
1
1998
54
0.010
Why?
Therapy, Computer-Assisted
1
1998
60
0.010
Why?
Thoracic Vertebrae
1
1998
74
0.010
Why?
Photography
1
1998
94
0.010
Why?
Tumor Virus Infections
1
1998
46
0.010
Why?
Receptors, Cytoplasmic and Nuclear
1
1999
217
0.010
Why?
Immunologic Deficiency Syndromes
1
1998
63
0.010
Why?
Spinal Fractures
1
1998
81
0.010
Why?
Cervical Vertebrae
1
1998
132
0.010
Why?
Herpesvirus 4, Human
1
1998
152
0.010
Why?
Herpesviridae Infections
1
1998
140
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1997
329
0.010
Why?
Acquired Immunodeficiency Syndrome
1
1998
227
0.010
Why?
Lumbar Vertebrae
1
1998
231
0.010
Why?
Mice, Inbred C57BL
1
2006
5408
0.010
Why?
Homeodomain Proteins
1
1999
494
0.010
Why?
Praziquantel
1
1995
5
0.010
Why?
Spinal Cord Injuries
1
1998
194
0.010
Why?
Ventriculoperitoneal Shunt
1
1995
38
0.010
Why?
RNA, Viral
1
1998
619
0.010
Why?
Carotid Stenosis
1
1995
84
0.010
Why?
Sensitivity and Specificity
1
1998
1834
0.010
Why?
Optic Chiasm
1
1992
19
0.010
Why?
Nerve Compression Syndromes
1
1992
23
0.010
Why?
Unconsciousness
1
1991
19
0.010
Why?
Amnesia
1
1991
43
0.010
Why?
Osmolar Concentration
1
1991
166
0.010
Why?
Pregnancy Complications, Neoplastic
1
1992
53
0.010
Why?
Headache
1
1992
150
0.010
Why?
Football
1
1991
78
0.010
Why?
Surveys and Questionnaires
1
2003
5394
0.010
Why?
Immunochemistry
1
1989
13
0.010
Why?
Autoradiography
1
1989
73
0.010
Why?
Hyperthyroidism
1
1989
28
0.000
Why?
Histocytochemistry
1
1989
83
0.000
Why?
Circadian Rhythm
1
1991
412
0.000
Why?
Neutrophils
1
1989
1202
0.000
Why?
Transcription, Genetic
1
1989
1415
0.000
Why?
Intraoperative Period
1
1982
53
0.000
Why?
Arteriovenous Malformations
1
1982
26
0.000
Why?
Cerebrospinal Fluid Shunts
1
1982
33
0.000
Why?
T-Lymphocytes
1
1989
1928
0.000
Why?
Phenotype
1
1989
3074
0.000
Why?
Gene Expression Regulation
1
1989
2543
0.000
Why?
Pregnancy
1
1992
6384
0.000
Why?
Lillehei's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)